Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 984 entries
View as:

A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)

Phase: N/A Priority: Normal
NCT ID: NCT06768658 Org: User:
Start: 03/02/22 End: 01/09/23 Due: 01/09/24

Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT02839902 Org: User:
Start: 12/27/16 End: 08/30/17 Due: 08/30/18

An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00734071 Org: User:
Start: 06/30/08 End: 03/31/09 Due: 03/31/10

A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04837222 Org: User:
Start: 06/07/21 End: 06/19/26 Due: 06/19/27

A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in India

Phase: N/A Priority: Normal
NCT ID: NCT06060067 Org: User:
Start: 03/29/24 End: 05/05/25 Due: 05/05/26

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care

Phase: N/A Priority: Normal
NCT ID: NCT06538064 Org: User:
Start: 04/29/25 End: 08/17/27 Due: 08/17/28

Dexlansoprazole in Asian Participants With Gastroesophageal Reflux Disease

Phase: N/A Priority: Normal
NCT ID: NCT02351960 Org: User:
Start: 03/19/15 End: 07/13/16 Due: 07/13/17

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00770835 Org: User:
Start: 03/31/09 End: 05/31/11 Due: 05/31/12

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01829477 Org: User:
Start: 04/30/13 End: 02/28/14 Due: 02/28/15

Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT04892888 Org: User:
Start: 08/01/22 End: 04/30/23 Due: 04/30/24

Expanded Access Program With Pevonedistat (Given With Azacitidine) for Adults With Higher-risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT04484363 Org: User:
Start: - End: - Due: -

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT03029143 Org: User:
Start: 03/29/17 End: 10/16/20 Due: 10/16/21

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT06095128 Org: User:
Start: 06/12/24 End: 07/09/27 Due: 07/09/28

Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01967251 Org: User:
Start: 09/30/15 End: 09/30/16 Due: 09/30/17

A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 Insertion

Phase: N/A Priority: Normal
NCT ID: NCT05419700 Org: User:
Start: 08/05/22 End: 09/01/23 Due: 09/01/24

A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT04272775 Org: User:
Start: 06/05/12 End: 02/15/19 Due: 02/15/20

Paricipant Preferences in the Treatment of Inflammatory Bowel Disease (IBD) in Europe

Phase: N/A Priority: Normal
NCT ID: NCT04597905 Org: User:
Start: 10/21/20 End: 01/31/21 Due: 01/31/22

RollOut -Pre-Rolled TachoSil in Laparoscopic Utilisation. A Non-Interventional Study

Phase: N/A Priority: Normal
NCT ID: NCT02685007 Org: User:
Start: 04/05/16 End: 08/14/17 Due: 08/14/18

Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT03410108 Org: User:
Start: 01/29/18 End: 07/28/21 Due: 07/28/22

A Study of Dexlansoprazole Modified Release (MR) in Gastroesophageal Reflux Disease (GERD) Participants in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT04311541 Org: User:
Start: 03/15/20 End: 01/31/22 Due: 01/31/23

Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB

Phase: N/A Priority: Normal
NCT ID: NCT03469349 Org: User:
Start: 05/01/18 End: 08/28/19 Due: 08/28/20

Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults

Phase: N/A Priority: Normal
NCT ID: NCT01967264 Org: User:
Start: 07/31/13 End: 08/31/13 Due: 08/31/14

Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02302066 Org: User:
Start: 12/05/14 End: 02/18/19 Due: 02/18/20

Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)

Phase: N/A Priority: Normal
NCT ID: NCT02089737 Org: User:
Start: 06/30/10 End: 07/31/12 Due: 07/31/13

Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」

Phase: N/A Priority: Normal
NCT ID: NCT02211638 Org: User:
Start: 06/13/11 End: 04/25/13 Due: 04/25/14